Adding TTFields to Taxol May Help Recurrent Ovarian Cancer Patients, Study Shows

Adding TTFields to Taxol May Help Recurrent Ovarian Cancer Patients, Study Shows
Adding Tumor Treating Fields (TTFields) — a therapy that uses electric fields to induce cell death — to weekly Taxol (paclitaxel) more than doubles the time to disease worsening or death in ovarian cancer patients who failed at least one prior therapy, a Phase 2 clinical trial shows. Compared to historical control participants, who live without disease progression for only

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *